drugset
drugset / Trial / NCT04205682

Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal

NCT04205682 ↗

Phase 0 Unknown 52 enrolled South West Sydney Local Health District South Eastern Sydney Local Health District · collabUniversity of Sydney · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will explore the effectiveness and tolerability of Cannabidiol (CBD) in the treatment of alcohol withdrawal symptoms in an inpatient setting, in a double-blind randomised placebo-controlled trial.

Timeline

Start
2020-01
Primary completion
2021-01
Completion
2021-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 800 mg —

Indications

alcohol dependence alcohol withdrawal